Synergy Pharma's (SGYP) Plecanatide NDA Accepted for Review by U.S. FDA; PDUFA Date Set
Tweet Send to a Friend
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) announced the U.S. Food and Drug Administration (FDA) has determined that the company’s New Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
